Skip to main content

Table 9 Correlation between presurgical OHIP-14 item score and patient’s perception of recovery

From: Patient’s perception of recovery after maxillary sinus floor augmentation with autogenous bone graft compared with composite grafts: a single-blinded randomized controlled trial

Question Autogenous bone graft 1:1 autogenous bone graft and DPBM 1:1 autogenous bone graft and BBGM
OHIP-14 score < 10 (no.: 12) Mean, range, SD OHIP-14 score ≥ 10 (no.: 8) Mean, range, SD p-value OHIP-14 score < 10 (no.: 10) Mean, range, SD OHIP-14 score ≥ 10 (no.: 10) Mean, range, SD p-value OHIP-14 score < 10 (no.: 15) Mean, range, SD OHIP-14 score ≥ 10 (no.: 5) Mean, range, SD p-value
Week
 Days, sick leave or off work? 0.0 (0–0), 0.0 0.4 (0–3), 0.3 0.00* 0.2 (0–2), 0.6 0.8 (0–7), 2.2 0.42 0.9 (0–3), 1.3 0.8 (0–2), 1.1 0.88
 Days, eating difficulties? 2.3 (0–6), 2.5 2.5 (0–7), 2.6 0.86 3.1 (0–11), 3.5 3.0 (0–7), 2.6 0.94 2.5 (0–7), 2.3 2.8 (0–6), 2.4 0.81
 Days, speech difficulties? 0.1 (0–1), 0.3 0.9 (0–7), 2.5 0.28 0.7 (0–7), 2.2 0.2 (0–2), 0.6 0.50 0.3 (0–3), 0.8 0.4 (0–2), 0.9 0.82
 Days, sleep affected? 1.0 (0–3), 1.7 1.1 (0–6), 2.2 0.91 0.0 (0–0), 0.0 0.7 (0–3), 1.1 0.06 0.3 (0–3), 0.8 0.4 (0–2), 0.9 0.82
 Days, physical activity affected? 0.6 (0–3), 1.1 1.3 (0–4), 1.8 0.29 1.5 (0–7), 2.6 2.3 (0–7), 2.5 0.49 2.8 (0–21), 5.5 1.3 (0–3), 1.3 0.56
Month
 Days, pain after surgery? 2.3 (0–8), 2.4 4.1 (1–7), 2.2 0.11 2.0 (0–7), 2.2 4.1 (1–10), 3.3 0.11 4.3 (0–20), 6.4 3.8 (0–7), 2.8 0.87
 Days, sick leave or off work? 0.0 (0–0), 0.0 0.4 (0–3), 1.1 0.22 0.3 (0–2), 0.7 1.6 (0–7), 2.6 0.14 1.1 (0–4), 1.6 0.8 (0–2). 1.1 0.70
 Work affected, (VAS) 17.6 (0–100), 34.5 24.1 (0–100), 37.9 0.70 12.9 (0–100), 31.1 14.7 (0–79), 26.9 0.89 17.1 (0–100), 34.1 20.4 (0–86), 37.3 0.86
 Days, work affected? 1.5 (0–7), 2.5 1.1 (0–3), 1.6 0.69 0.4 (0–3), 1.0 2.6 (0–7), 3.0 0.04* 0.7 (0–3), 1.2 1.4 (0–4), 1.9 0.34
 Eating difficulties, (VAS) 62.6 (0–100), 42.6 52.1 (0–98), 41.5 0.59 52.7 (0–100), 48.3 48.3 (0–100), 44.5 0.83 56.8 (0–100), 42.6 54.0 (0–100), 47.5 0.90
 Days, eating difficulties? 3.3 (0–14), 4.0 3.1 (0–7), 2.2 0.90 2.6 (0–10), 3.4 4.7 (1–14), 3.9 0.22 1.9 (0–7), 2.0 2.8 (0–7), 2.8 0.44
 Speech changes, (VAS) 0.1 (0–1), 0.3 8.1 (0–58), 20.2 0.18 3.3 (0–31), 9.8 7.3 (0–73), 23.1 0.62 7.8 (0–100), 25.7 17.2 (0–86), 38.5 0.54
 Days, speech changes? 0.0 (0–0), 0.0 0.9 (0–7), 2.5 0.22 1.4 (0–14), 4.4 1.5 (0–14), 4.4 0.96 0.4 (0–3), 0.9 0.2 (0–1), 0.4 0.64
 Sleep disturbances? (VAS) 2.2 (0–14), 4.7 34.3 (0–100), 44.5 0.02* 13.0 (0–100), 32.0 29.3 (0–100), 40.0 0.33 14.9 (0–97), 27.5 39.4 (0–100), 52.2 0.19
 Days, sleep affected? 0.4 (0–3), 1.0 1.7 (0–7), 2.6 0.13 0.8 (0–7), 2.2 1.6 (0–7), 2.4 0.45 0.7 (0–5), 1.4 0.6 (0–2), 0.9 0.88
  1. BBGM biphasic bone graft material, DPBM deproteinized porcine bone mineral, OHIP-14 Oral Health Impact Profile-14, SD standard deviation, VAS visual analogue scale (0 = minimal to 100 = maximum)
  2. *Statistically significant